On November 6, 2023 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, reported that members of its management team will participate in the UBS Biopharma Conference, November 8-9th in Miami Beach, FL, the Piper Sandler 35th Annual Healthcare Conference, November 28-30th, in New York, NY, and the Evercore ISI 6th Annual HealthCONx Conference, November 28-30th, in Miami, Florida (Press release, CymaBay Therapeutics, NOV 6, 2023, View Source [SID1234637019]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

UBS Biopharma Conference
Date: Wednesday, November 8
Time: 11:30am Eastern Time, Fireside Chat
Webcast: View Source

Piper Sandler 35th Annual Healthcare Conference
Date: Tuesday, November 28
Time: 2:00pm Eastern Time, Fireside Chat
Webcast: View Source

Evercore ISI 6th Annual HealthCONx Conference
Date: Wednesday, November 29
Time: 1:20pm Eastern Time, Fireside Chat
Webcast: View Source